The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells

BACKGROUND: There are some limitations of standard chemotherapy for acute leukemia. Vincristine and doxorubicin are commonly used for acute leukemia, but they may induce serious side effects such as cardiomyopathy and neurotoxicity. Furthermore, chemotherapy resistance occurs more and more frequentl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Epigenetics
Main Authors: Tu, Huang-Ju, Lin, Yi-Jyun, Chao, Min-Wu, Sung, Ting-Yi, Wu, Yi-Wen, Chen, Yi-Ying, Lin, Mei-Hsiang, Liou, Jing-Ping, Pan, Shiow-Lin, Yang, Chia-Ron
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310984/
https://ncbi.nlm.nih.gov/pubmed/30594243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0595-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados